Literature DB >> 12776279

Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient.

Seoung Woo Lee1, Joon Ho Song, Gyeong A Kim, Hee Jung Lim, Moon-Jae Kim.   

Abstract

BACKGROUND: Brain natriuretic peptide (BNP) is released into circulation in response to ventricular dilatation and pressure overload. Plasma BNP concentration correlates with left ventricular mass and dysfunction, which is prevalent in hemodialysis (HD) patients.
METHODS: To evaluate the potential of BNP level for determination of hydration status, we measured inferior vena caval diameter (IVCD) and BNP levels and performed bioimpedance analysis in 49 HD patients.
RESULTS: Pre-HD BNP levels remained unchanged after HD. Agreement between IVCD and pre-HD BNP level in overhydration was significant (kappa = 0.304). The area under the receiver operating characteristic (ROC) curve for overhydration was 0.819 for pre-HD BNP level. When extracellular fluid/total-body water (ECF/TBW) ratios of HD patients were compared with those of 723 controls, pre- and post-HD BNP levels were significantly greater in overhydrated patients. The area under the ROC curve for overhydration by ECF/TBW ratio was 0.781 for pre-HD BNP level. However, there was no significance for pre- or post-HD BNP levels on assessment of normohydration or underhydration. Pre-HD BNP level correlated significantly with post-HD BNP level, post-HD diastolic blood pressure, pulse pressure, and ECF/TBW ratio. IVCD correlated significantly with post-HD BNP level.
CONCLUSION: BNP level seems to have a limited potential for assessment of overhydration in HD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776279     DOI: 10.1016/s0272-6386(03)00358-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  18 in total

Review 1.  Assessing cardiovascular risk in children with chronic kidney disease. B-type natriuretic peptide: a potential new marker.

Authors:  Gema Ariceta; Ellen R Brooks; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2005-08-05       Impact factor: 3.714

2.  Relationship of brain natriuretic peptide concentrations to left ventricular function and adverse outcomes in children with end-stage renal disease undergoing hemodialysis.

Authors:  Sana Ouali; Iheb Bougmiza; Saoussen Abroug; Asma Omezzine; Helmi Ben Salem; Elyes Neffeti; Fahmi Remedi; Ali Bouslema; Abdelaziz Harabi; Essia Boughzela
Journal:  Pediatr Cardiol       Date:  2011-02-20       Impact factor: 1.655

3.  N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients.

Authors:  Magid A Fahim; Andrew Hayen; Andrea R Horvath; Goce Dimeski; Amanda Coburn; David W Johnson; Carmel M Hawley; Scott B Campbell; Jonathan C Craig
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-24       Impact factor: 8.237

4.  Plasma Brain Natriuretic Peptide Levels in Children with Chronic Kidney Disease and Renal Transplant Recipients: A Single Center Study.

Authors:  Anastasia Garoufi; Aikaterini Koumparelou; Varvara Askiti; Panagis Lykoudis; Andromachi Mitsioni; Styliani Drapanioti; Georgios Servos; Maria Papadaki; Dimitrios Gourgiotis; Antonios Marmarinos
Journal:  Children (Basel)       Date:  2022-06-19

5.  Creation of dialysis vascular access with normal flow increases brain natriuretic peptide levels.

Authors:  Jan Malík; Vladimir Tuka; Zdislava Krupickova; Eva Chytilova; Robert Holaj; Marcela Slavikova
Journal:  Int Urol Nephrol       Date:  2009-02-24       Impact factor: 2.370

Review 6.  Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?

Authors:  Thanat Chaikijurajai; Hernan Rincon Choles; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-09-17

7.  B-type natriuretic peptide is not a volume marker among patients on hemodialysis.

Authors:  Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2013-03-22       Impact factor: 5.992

8.  Biomarkers in predicting mortality and treatment in hemodialysis patients.

Authors:  Angela Yee-Moon Wang
Journal:  F1000 Med Rep       Date:  2009-03-17

9.  The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients.

Authors:  Murugan Sivalingam; Enric Vilar; Suresh Mathavakkannan; Ken Farrington
Journal:  BMC Nephrol       Date:  2015-12-29       Impact factor: 2.388

10.  B-type natriuretic peptide and prognosis of end-stage renal disease: a meta-analysis.

Authors:  Yun-Jiu Cheng; Feng-Juan Yao; Li-Juan Liu; Kai Tang; Xiao-Xiong Lin; Wei-Jie Li; Jing Zhang; Su-Hua Wu
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.